ACTBP2 |
|
ACTB pseudogene 2
|
|
|
0.861 |
0.077 |
ATD |
|
asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome)
|
|
|
0.656 |
0.731 |
ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
HOXB@ |
|
homeobox B cluster
|
|
|
0.631 |
0.538 |
HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
MAA |
|
microphthalmia or anophthalmia and associated anomalies
|
|
|
0.666 |
0.577 |
MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
OAP |
|
osteoarthrosis, precocious
|
|
|
0.792 |
0.192 |
PTMAP4 |
|
prothymosin alpha pseudogene 4
|
|
|
0.638 |
0.731 |
PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
RNU2-1 |
|
RNA, U2 small nuclear 1
|
|
|
0.760 |
0.385 |
SNORD15A |
|
small nucleolar RNA, C/D box 15A
|
|
|
0.653 |
0.577 |
SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
SSAV1 |
|
simian sarcoma-associated virus 1/gibbon ape leukemia virus-related endogenous retroviral element 1
|
|
|
0.695 |
0.269 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
TRC-GCA24-1 |
|
tRNA-Cys (GCA) 24-1
|
|
|
0.729 |
0.346 |
TRE-TTC3-1 |
|
tRNA-Glu (anticodon TTC) 3-1
|
|
|
0.751 |
0.269 |
XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |